Table 6.
0.4 mg | 0.8 mg | Placebo | |
---|---|---|---|
(n = 501) | (n = 492) | (n = 493) | |
Dizziness | 14.9% | 17.1% | 10.1% |
Abnormal ejaculation | 8.4% | 18.1% | 0.2% |
Asthenia/fatigue | 7.8% | 8.5% | 5.5% |
Libido decreased | 1.0% | 2..0% | 1.2% |
Amblyopia | 0.2% | 2.0% | 0.4% |
0.4 mg | 0.8 mg | Placebo | |
---|---|---|---|
(n = 501) | (n = 492) | (n = 493) | |
Dizziness | 14.9% | 17.1% | 10.1% |
Abnormal ejaculation | 8.4% | 18.1% | 0.2% |
Asthenia/fatigue | 7.8% | 8.5% | 5.5% |
Libido decreased | 1.0% | 2..0% | 1.2% |
Amblyopia | 0.2% | 2.0% | 0.4% |